Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns

Similar documents
CHROMOSOMAL MICROARRAY (CGH+SNP)

Sharan Goobie, MD, MSc, FRCPC

Approach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

National Medical Policy

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

Genetic Testing 101: Interpreting the Chromosomes

CHROMOSOME MICROARRAY TESTING

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

CHROMOSOME MICROARRAY TESTING (NON-ONCOLOGY CONDITIONS)

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016

Prenatal Diagnosis: Are There Microarrays in Your Future?

Genetic Testing for the Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies

Faravareh Khordadpoor (PhD in molecular genetics) 1- Tehran Medical Genetics Laboratory 2- Science and research branch, Islamic Azad University

Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Section: Medicine Effective Date: January15, 2016 Subsection: Pathology/Laboratory Original Policy Date: December 7, 2011 Subject:

Cytogenetics 101: Clinical Research and Molecular Genetic Technologies

SEAMLESS CGH DIAGNOSTIC TESTING

Genetic Testing for Single-Gene and Multifactorial Conditions

Medical Policy. MP Invasive Prenatal (Fetal) Diagnostic Testing

Protocol. Genetic Testing for Developmental Delay and Autism Spectrum Disorder

Implementation of the DDD/ClinGen OGT (CytoSure v3) Microarray

CLINICAL MEDICAL POLICY

CNV Detection and Interpretation in Genomic Data

Whole-Genome SNP Array Analysis Genomic Complexity and Clinical Relevance in Prenatal, Postnatal, and Oncology Testing

Clinical evaluation of microarray data

Corporate Medical Policy

Chromosome microarray analysis in routine prenatal diagnosis practice: a prospective study on 3000 consecutive clinical cases

PATIENT CONSENT FORM Preimplantation Genetic Screening (PGS) 24 Chromosome Aneuploidy and Translocation Screening with acgh

What s the Human Genome Project Got to Do with Developmental Disabilities?

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University

Genetic Counselling in relation to genetic testing

Increasing the Sensitivity of Genomic Assays Permits a Higher Resolution Study of the Human Genome. Our Current Knowledge of Genetics and Genomics

Clinical Policy Title: Array comparative genomic hybridization testing

Prior Authorization Review Panel MCO Policy Submission

Genomic structural variation

Clinical Interpretation of Cancer Genomes

Canadian College of Medical Geneticists (CCMG) Cytogenetics Examination. May 4, 2010

Clinical Cytogenomics Laboratory. Laboratory. Leading diagnostics for better medicine. Beaumont

Genetic Testing for Single-Gene and Multifactorial Conditions

Clinical Policy Title: Array comparative genomic hybridization testing

Section: Genetic Testing Last Reviewed Date: April Policy No: 58 Effective Date: July 1, 2014

GENOME-WIDE ANALYSIS BY SNP ARRAY

Structural Chromosome Aberrations

Invasive Prenatal (Fetal) Diagnostic Testing

Genome-wide analysis by SNP Array

Seven cases of intellectual disability analysed by genomewide SNP analysis. Rodney J. Scott

Clinical Cytogenetics September 14 th 20 th, 2014 Goldrain, South Tyrol, Italy

SNP Microarray. Prenatal

Why did this happen? Genetic and teratologic considerations in CHD Jennifer Kussmann, MS,CGC. The Children's Mercy Hospital, 2014.

Human Genetic Variation Copy Number Variation

Case Report Prenatal Diagnosis of Cystic Hygroma related to a Deletion of 16q24.1 with Haploinsufficiency of FOXF1 and FOXC2 Genes

Understanding the Human Karyotype Colleen Jackson Cook, Ph.D.

Case 1B. 46,XY,-14,+t(14;21)

Updating penetrance estimates for syndromes with variable phenotypic manifestation. Adele Corrigan June 27th

New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads

22q11.2 DELETION SYNDROME. Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona)

Genetics update and implications for (General) Practice

FEP Medical Policy Manual

PROVIDER POLICIES & PROCEDURES

Addressing the challenges of genomic characterization of hematologic malignancies using microarrays

(2018) Keywords: Balanced rearrangement; Chromosomal microarray; genetic testing; mosaicism; UPD

Clinical Genomics. Ina E. Amarillo, PhD FACMGG

Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology

Chromosome Microarray Analysis (CMA)

GENETICS ROTATION OBJECTIVES MATERNAL-FETAL MEDICINE FELLOWSHIP

Application of Whole Genome Microarrays in Cancer: You should be doing this test!!

MP Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies

Genetics and Genomics: Applications to Developmental Disability

SNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation carrier and normal blastocysts

Investigating rare diseases with Agilent NGS solutions

Diagnosis of parental balanced reciprocal translocations by trophectoderm biopsy and comprehensive chromosomal screening

FEP Medical Policy Manual

No mutations were identified.

Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment).

Global variation in copy number in the human genome

review Genetics IN Medicine 13

Number: Policy *Please see amendment for Pennsylvania Medicaid at the end of this CPB.

CNV detection. Introduction and detection in NGS data. G. Demidov 1,2. NGSchool2016. Centre for Genomic Regulation. CNV detection. G.

%(6/31) [DOI] /j.issn

LIST OF INVESTIGATIONS

Genomic complexity and arrays in CLL. Gian Matteo Rigolin, MD, PhD St. Anna University Hospital Ferrara, Italy

Structural Variation and Medical Genomics

Current controversies in prenatal diagnosis 3: is conventional chromosome analysis necessary in the post-array CGH era?

Dr Dipti Deshmukh. Mayu Uemura. 11th September Introduction

7.1 Molecular Characterization of Fragile X Syndrome

increment in the genome to calculate the statistic of read count. Three billions according to the reference

RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017

Chromosome Abnormalities

Copy Number Variants of Uncertain Significance in Prenatal diagnosis Are the Goalposts Moving? Lisa Burvill-Holmes Bristol Genetics Laboratory

Research Article Prenatal Diagnosis of Central Nervous System Anomalies by High-Resolution Chromosomal Microarray Analysis

MPS for translocations

Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit

Targeted qpcr. Debate on PGS Technology: Targeted vs. Whole genome approach. Discolsure Stake shareholder of GENETYX S.R.L

Molecular and Clinical Characterization of Syndromes Associated With Intellectual Disability

chromosomal anomalies and mental pdf Chapter 8: Chromosomes and Chromosomal Anomalies (PDF) Chromosomal abnormalities -A review - ResearchGate

What lies beneath: challenges in reporting SNP array results. Jonathan Waters

Transcription:

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns جواد کریمزاد حق PhD of Medical Genetics آزمايشگاه پاتوبيولوژي و ژنتيك پارسه

Array CGH (comparative genomic hybridization)/ (single nucleotide polymorphism) SNP Array I:Technical Principles II: Clinical Applications

I:Technical Principles Array-CGH, SNP-Array

acgh: Array comparative genomic hybridization (also microarray-based comparative genomic hybridization, array CGH, acgh) is a molecular cytogenetic technique for the detection of chromosomal copy number changes on a genome wide and high-resolution scale.

SNP array is a type of DNA microarray which is used to detect polymorphisms within a population. A single nucleotide polymorphism (SNP), a variation at a single site in DNA, is the most frequent type of variation in the genome.

Differences in the ability to resolve genomic changes between these arrays I:Array CGH Gain Detection of CNVs Loss Detection of CNVs (Unbalanced chromosomal rearrangements) single-exon copy number variants (CNVs) Resolution 8x60k, 4x180k, 2x400k, 1M SurePrint G3 Custom CGH+SNP (LOH-Analayse, Delectation of UPD) Agilent II: SNP Array Gain Detection of CNVs Loss Detection of CNVs (Unbalanced chromosomal rearrangements) Determining disease susceptibility (Genome wide association study) Loss Of Heterozygosity (LOH) higher sensitivity for the detection of low-level mosaic aneuploidies and chimerism indicate uniparental disomy (UPD) Detection of Polyploidy, MaternalContamination Parental DNA needed!! Resolution 2.7 M, 1.8M (SNP 6.0) Affymetrix

DNA Extraction To Annotation DGV/DECIPHER/ISCA/UCSC/OMIM, Gene Reviews and recently published reviews Benign (Literature reports! no genes!! enriched in repetitive sequences, short size), Definitely pathologic (Literature reports! Dom. Pattern (HI), high densities of functional elements, large size) Uncertain clinical Significance (likely pathologic: small database reports, one gene!//likely benign: small databases polymorph in general population// unclassified: Dosage effect of, genes is unknown, Inherited Incidental Finding (for. example: risk of neoplasia :TP53,RB) Difficult Interpretation by high resolution(by high resolution)

Copy Number Variations (CNVs) Copy number variation is a type of structural variation: specifically, it is a type of duplication or deletion event that affects a considerable number of base pairs ~ 4.8-9.5% of the human genome can be classified as copy number variations and approximately 100 genes that can be completely deleted without producing apparent phenotypic consequences. Nature Reviews Genetics. 16: 172 183

II: Clinical Applications

The majority (>95%) of benign CNVs in humans are <100 kb in size

Clinical Applications 1. PGD/PGS/PND 2. Abortion 3. Ultrasonographic detected structural abnormalities of fetus 4. non-syndromic developmental delay/intellectual disability (DD/ID), Multiple Congenital Anomalies (MCA) not specific to a well-delineated genetic syndrome, Autism Spectrum Disorders (ASD) and children with growth retardation and speech delay

1. PGD/PGS/PND PGS identifies chromosomally normal embryos ("euploid" embryos) for transfer to the uterus in the last step of an IVF cycle. Patients with a history of recurrent miscarriage or failed IVF cycles, which can be linked to chromosomal abnormality, may benefit from PGS. In addition, patients may also undergo PGS with the goal of transferring a single embryo. Blastomer biopsy of a 3-day-old embryo Trophectoderm biopsy of a 5-day-old embryo

2. Abortions In about 50% of first trimester spontaneous abortion the cause remains undetermined after standard cytogenetic investigation. array-cgh: detects abnormalities in a further ~10% of spontaneous abortion specimens considered to be normal using standard cytogenetic methods Spontaneous abortion and stillbirth by array-based comparative genomic hybridization 43 fetuses with spontaneous abortion and stillbirth. 32 (74.4%) of the samples, which included 26 (60%) aneuploidies and 10 (23%) pathogenic CNV. 2015 Jun;32(3):348-52. doi: 10.3760/cma.j.issn.1003-9406.2015.03.010.

3. Ultrasonographic detected structural abnormalities of fetus Chromosomal Microarray Analysis (CMA) can identify also imbalanced chromosomal aberration in approximately 6% of fetuses with ultrasonographic abnormalities with a normal karyotype result. Anencephaly Microcephaly Cleft palate Polyhydramnios Encephalocele Cystic hygroma Hydrops fetalis Dandy-Walker malformation Polydactyly Holoprosencephaly Oligohydramnios

Result: arr[hg19] 22q11.21(18628073_21857001)x3 Microarray CGH The gain is between locus q11.21 starting from 18628073bp to 21857001bp ranging 3.23Mb.

Two breakpoints between USP18 and CLTCL1 locus in the centromer section and LZTR1 and HIC2 locus in the telomeric section, that contains a genome duplication sizing about 2-3 Mb. This microduplication was also identified exactly in the father of the fetus.

4. non-syndromic developmental delay/intellectual disability (DD/ID), multiple congenital anomalies (MCA) not specific to a well-delineated genetic syndrome, autism spectrum disorders (ASD) and children with growth retardation and speech delay Array CGH is recommended as the first-tier evaluation in individuals with developmental disabilities or congenital anomalies not specific to a well-delineated mono genetic syndrome. The value of acgh screening as a first-tier test in children with multiple congenital anomalies has been studied and consensus adopted. Disease-causing CNVs are found in 5% 10% of cases of autism. Among 1792 patients (DD/MCA/ASD), 13.1% had clinically relevant results, either abnormal (n 131; 7.3%) or variants of possible significance (VPS; n 104; 5.8%). Genetics IN Medicine Volume 13, Number 9, September 2011

Confirm of array results /FISH /Realtime-PCR or PCR-capillary

Conclusion Array CGH/SNP Indications Example I: A parents with known balanced Translocation or marker-chromosome or a ring X-chromosome, Inversion wit an affected person, de novo translocation (8-10%) (one of parents has an chromosomal rearrangement without clinical features) PGD/PGS/CVS/Amniocentesis/cordocentesis Example II: IVF Failures, Recurrent pregnancy loss, Abortions PGS/POC Example III: Fetus with structural anomalies IUFD, IUGR : QF- PCR, FISH, MLPA and karyotype results are normal! Example IV: ID/DD, ASD, MCA Prenatal diagnostic Postnatal diagnostic For Choosing of suitable Array resolutions the physicians should be counseling with Genetics-Laboratories (Examples: 60 k for Abortion, 180 k for ASD)